CL2008001462A1 - Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto - Google Patents

Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto

Info

Publication number
CL2008001462A1
CL2008001462A1 CL2008001462A CL2008001462A CL2008001462A1 CL 2008001462 A1 CL2008001462 A1 CL 2008001462A1 CL 2008001462 A CL2008001462 A CL 2008001462A CL 2008001462 A CL2008001462 A CL 2008001462A CL 2008001462 A1 CL2008001462 A1 CL 2008001462A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
phospholipid
preserving
solution
contact lenses
Prior art date
Application number
CL2008001462A
Other languages
English (en)
Spanish (es)
Inventor
Malay Ghosh
Masood Chowhan
L Wayne Schneider
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of CL2008001462A1 publication Critical patent/CL2008001462A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2008001462A 2007-05-18 2008-05-19 Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto CL2008001462A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93893907P 2007-05-18 2007-05-18

Publications (1)

Publication Number Publication Date
CL2008001462A1 true CL2008001462A1 (es) 2009-01-02

Family

ID=39627450

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001462A CL2008001462A1 (es) 2007-05-18 2008-05-19 Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto

Country Status (15)

Country Link
US (2) US20080287395A1 (enExample)
EP (1) EP2155271B1 (enExample)
JP (1) JP5620264B2 (enExample)
KR (1) KR20100016091A (enExample)
CN (1) CN101678140A (enExample)
AR (1) AR066901A1 (enExample)
AU (1) AU2008254858B2 (enExample)
BR (1) BRPI0811188A2 (enExample)
CA (1) CA2683283A1 (enExample)
CL (1) CL2008001462A1 (enExample)
ES (1) ES2627437T3 (enExample)
MX (1) MX2009011713A (enExample)
TW (1) TW200904485A (enExample)
UY (1) UY31094A1 (enExample)
WO (1) WO2008144494A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110010788A (ko) * 2008-05-28 2011-02-07 알콘 리서치, 리미티드 자기보존 에멀젼
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
US20100160342A1 (en) * 2008-12-22 2010-06-24 Alcon Research, Ltd. Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the Eye
CN101473832B (zh) * 2009-02-17 2012-05-09 上海斯贝生物科技有限公司 一种新型环保型消毒液
JP2011021002A (ja) * 2009-06-16 2011-02-03 Lion Corp 眼科用組成物
TWI547522B (zh) * 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
BR112012028308B1 (pt) * 2010-05-05 2021-09-28 Alcon Inc. Formulações oftálmicas de galactomanano estabilizadas, e seu método de fabricação
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
US10130576B2 (en) * 2012-11-13 2018-11-20 Johnson & Johnson Consumer Inc. Oral care compositions
US20140134115A1 (en) * 2012-11-13 2014-05-15 Mcneil-Ppc, Inc. Oral care compositions
US9248928B2 (en) * 2012-12-21 2016-02-02 Coopervision International Holding Company, Lp Methods of manufacturing contact lenses for delivery of beneficial agents
CA2966489A1 (en) * 2014-11-03 2016-05-12 Nicolai Vladimirovich Bovin Antimicrobial surface treatment
US9744192B2 (en) * 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis
CN108310442B (zh) * 2017-01-17 2021-08-27 台北科技大学 眼科用组合物
GB201813229D0 (en) 2018-08-14 2018-09-26 Ocutec Ltd Formulation
CN110200015B (zh) * 2019-05-21 2020-10-30 乐清市泰博恒电子科技有限公司 一种抗病毒生物肽护理液及其制备方法和应用
WO2021156623A1 (en) 2020-02-07 2021-08-12 Ocutec Limited Optimised contact lens package
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法
US20240118559A1 (en) 2022-09-27 2024-04-11 Coopervision International Limited Sustained release of oleic acid from contact lenses

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5089053A (en) * 1989-11-09 1992-02-18 Polymer Technology Corporation Contact lens cleaning material and method
US5648348A (en) * 1991-10-28 1997-07-15 Mona Industries, Inc. Phospholipid antimicrobial compositions
US5286719A (en) * 1991-10-28 1994-02-15 Mona Industries, Inc. Phospholipid virucidal compositions
ES2153365T3 (es) * 1991-10-28 2001-03-01 Dennis L Fost Composiciones fosfolipidas antimicrobianas.
JPH08507884A (ja) * 1993-03-12 1996-08-20 アラーガン、インコーポレイテッド フェロモン添加剤を含有するアイケア用品およびその使用方法
CA2098429A1 (en) * 1993-03-30 1994-10-01 Yvette Lynn Touchet Preserved wet wipes
EP0724622A1 (en) * 1993-07-01 1996-08-07 Allergan, Inc. Contact lens cleaning solution based on quaternary ammonium phosphate esters
AU2277395A (en) * 1994-04-11 1995-10-30 Allergan, Inc. Phospholipid preservation of hydrogen peroxide-containing compositions
CA2166722A1 (en) * 1994-05-06 1995-11-16 Manoj L. Maniar Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
IL127955A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Pharmaceutical composition containing acid addition salt of basic drug
WO1998006381A1 (en) * 1996-08-09 1998-02-19 Alcon Laboratories, Inc. Preservative systems for pharmaceutical compositions containing cyclodextrins
US6120758A (en) * 1998-07-16 2000-09-19 Shaklee Corporation Preservative system for topically applied products
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US20030207890A1 (en) * 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
MX2009000885A (es) * 2006-07-25 2009-02-05 Osmotica Corp Soluciones oftalmicas.
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength

Also Published As

Publication number Publication date
UY31094A1 (es) 2008-07-03
KR20100016091A (ko) 2010-02-12
EP2155271B1 (en) 2017-03-08
CA2683283A1 (en) 2008-11-27
US20150209466A1 (en) 2015-07-30
JP2010527933A (ja) 2010-08-19
CN101678140A (zh) 2010-03-24
ES2627437T3 (es) 2017-07-28
AR066901A1 (es) 2009-09-23
WO2008144494A8 (en) 2009-12-10
BRPI0811188A2 (pt) 2014-10-07
EP2155271A1 (en) 2010-02-24
WO2008144494A1 (en) 2008-11-27
US20080287395A1 (en) 2008-11-20
AU2008254858B2 (en) 2013-06-20
TW200904485A (en) 2009-02-01
AU2008254858A1 (en) 2008-11-27
MX2009011713A (es) 2009-11-10
JP5620264B2 (ja) 2014-11-05

Similar Documents

Publication Publication Date Title
CL2008001462A1 (es) Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto
CO6511251A2 (es) Compuestos quimicos
BR112012015721A2 (pt) modificação covalente de proteínas dirigida por ligante
BR112018009297A8 (pt) composição de limpeza e desinfecção
CL2015003188A1 (es) Divisional de la solicitud 578-2014 por composición controladora de enfermedades en plantas y métodos para controlar enfermedades en plantas
CL2010000829A1 (es) Metodo para tratar plantas que comprende aplicar a las plantas una composicion liquida que contiene ente 0,3 a 300 miligramos de uno o mas ciclopropenos por litro de dicha composicion.
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
CL2010001526A1 (es) Compuestos derivados de isonicotinamida, moduladores de la estearoil-coa-desaturasa; composicion farmaceutica que comprende un compuesto;utiles para tratar enfermedades relacionadas con dislipidemia y trastornos del metabolismo de lipidos.
CL2007003452A1 (es) Metodo para prevenir enfermedades de plantas causadas por microorganismos, fitopatogenos, que comprende aplicar la quinolina 3-(5-fluor-3,3-dimetil-3,4-dehidroisoquinolin-1-il)quinolina en tratamiento directo a las semillas.
ECSP10010015A (es) Inhibidores de proteasoma
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
CL2017000498A1 (es) Una formulación de n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforida (galns)(divisional solicitud 219-2013)
BRPI0911176A2 (pt) Métodos de extinção melhorados para inativação de patógeno de células vermelhas sanguíneas
CO6680710A2 (es) Impalnte con calcio en superficie, y método de modificación de la superficie de un impalnte para dotar a dicha superficie de calcio
CL2012002421A1 (es) Composicion que comprende un fluido vertible no acuoso y gotas dispersadas en dicho fluido vertible; metodo de tratamiento de plantas o partes de ellas que comprende ponerlas en contacto con la composicion antes mencionada.
GT200900233A (es) Tratamientos de bananos
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
BR112017023750A2 (pt) desintoxicação de fatores de virulência microbiana na cavidade bucal
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
CL2009001488A1 (es) Metodo para tratar una muestra liquida que contiene particulas microbiologicas.
MX2019005751A (es) Tratamiento de enfermedades e infecciones de las vias respiratorias con composiciones de acido ascorbico.
AR068574A1 (es) Metodos para esterilizar lentes oftalmicas
CL2008001281A1 (es) Metodo para limpiar y/o desinfectar un lente de contacto; formulacion para desinfectar un lente de contacto que comprende un amonoacido n-halogenado y un agente de transferencia de fase; composicion farmaceutica que comprende un aminoacido n-halogenado y un agente de transferencia de fase; y metodo para desinfectar o limpiar superficies
CL2009000065A1 (es) Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.
CL2008001279A1 (es) Metodo para mejorar la actividad antimicrobiana de una formulacion que comprende un aminoacido n-halogenado que comprende un agente de transferencia de fase; formulacion; metodo para desinfectar superficies y lentes de contacto; metodo para tratar una infeccion de tejido y para tratar infecciones respiratorias.